BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6722805)

  • 1. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
    Parsons PG
    Cancer Res; 1984 Jul; 44(7):2773-8. PubMed ID: 6722805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
    Parsons PG; Carter FB; Morrison L; Regius Mary Sister
    Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide resistance developed in a human melanoma cell line.
    Boon MH; Parsons PG
    Cancer Treat Rep; 1984 Oct; 68(10):1239-46. PubMed ID: 6525597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines.
    Goss P; Parsons PG
    Cancer Res; 1977 Jan; 37(1):152-6. PubMed ID: 830403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells.
    Hansson J; Lewensohn R; Ringborg U; Nilsson B
    Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
    Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U
    Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
    Ross WE; Ewig RA; Kohn KW
    Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.
    Hayward IP; Parsons PG
    Cancer Res; 1984 Jan; 44(1):55-8. PubMed ID: 6690060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME; Siemann DW
    Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY; Li L; Keating MJ; Plunkett W
    Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
    Goldenberg GJ
    Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.
    Parsons PG; Morrison LE
    Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
    Schecter RL; Alaoui-Jamali MA; Woo A; Fahl WE; Batist G
    Cancer Res; 1993 Oct; 53(20):4900-6. PubMed ID: 8402679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced level of DNA cross-links and sister chromatid exchanges in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant rat brain tumor cells.
    Bodell WJ; Rupniak HT; Rasmussen J; Morgan WF; Rosenblum ML
    Cancer Res; 1984 Sep; 44(9):3763-7. PubMed ID: 6744295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
    Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S
    Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
    Brox LW; Gowans B; Belch A
    Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
    Hansson J; Lewensohn R; Ringborg U
    Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
    Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
    Hansson J; Lewensohn R; Ringborg U
    Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.